Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
The immunogenetics of multiple sclerosis: A comprehensive review.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Acquired immune demyelinating neuropathies.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
[Optic neuropathy after retrobulbar neuritis in multiple sclerosis : Are optical coherence tomography and magnetic resonance imaging useful and necessary follow-up parameters?].
A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis.
The risks for falls and fractures in multiple sclerosis.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
The endocannabinoid system: a putative role in neurodegenerative diseases.
Retinal thickness in pediatric multiple sclerosis.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Cerebral arterial and venous blood flow in adolescent multiple sclerosis patients and age-matched controls using phase contrast MRI.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Gait and six-minute walk performance in persons with multiple sclerosis.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India.
Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: Preliminary evidence from a randomized controlled trial.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
[Uveitis in multiple sclerosis : Overview and perspectives.]
Differential patterns of spinal cord and brain atrophy in NMO and MS.
Pages
« first
‹ previous
…
341
342
343
344
345
346
347
348
349
…
next ›
last »